抗高血压药物与老年患者骨折风险之间的关联:一项横截面研究
Muhammad D Nadeem1, Junaid Ali2, Shahin Shah3
1Medicine, University Hospitals Birmingham NHS Foundation Trust, Birmingham, GBR.
Cureus
|October 21, 2024
概括
使用抗高血压药物,特别是利尿剂的老年患者面临骨折风险增加. 这强调了需要谨慎管理,平衡血压控制和老年人的骨健康问题.
科学领域:
- 老年学是指老年学的学科.
- 药理学 药理学是指药理学的学科.
- 整形外科 整形外科 整形外科
背景情况:
- 抗高血压药物在老年人中广泛用于心血管健康.
- 人们担心这些药物对老年人骨健康和骨折风险的影响.
研究的目的:
- 调查65岁及以上个体的抗高血压药物使用与骨折风险之间的关联.
主要方法:
- 一项横截面研究分析了299名高血压老年患者的数据.
- 后勤回归模型评估了抗高血压剂使用和骨折之间的联系,控制混因素.
主要成果:
- 88名参与者 (29.43%) 患有骨折,女性和75-84岁的人群的患病率更高.
- 利尿剂的使用与骨折风险增加2.3倍相关 (OR2.30,p=0.037).
- 跌倒,移动性问题,骨质疏松症和 incontinence 是重要的骨折预测因素.
结论:
- 服用抗高血压药物,特别是利尿剂的老年患者需要仔细评估骨折风险.
- 临床医生必须权衡血压管理的好处与潜在的骨健康影响.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
394
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
394
Hypertension IV: Drug Therapy and Lifestyle Modifications
2
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
2
Heart Failure V: Medical Management
1
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
1
Antihypertensive Drugs: Direct Renin Inhibitors
499
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
499
Antihypertensive Drugs: Angiotensin II Receptor Blockers
592
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
592
Antihypertensive Drugs: Thiazide-Class Diuretics
548
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
548


